Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
  4. Fast Track Articles
  5. Fast Track Article
image of Discovery of a Novel Co-crystal of Chrysin and Oroxylin a with Anticancer Properties from Leaves of Oroxylum indicum

Abstract

Background

As the number of new cancer cases increases every year, there is a necessity to develop new drugs for the treatment of different types of cancers. Plants' resources are considered to be huge reservoirs for therapeutic agents in nature. Among all the medicinal plants, is one of the most widely used medicinal plants in India, China, and Southeast Asian countries. Combinatorial drug treatment, on the other hand, is favored over single drug treatment in order to target multiple biomolecular moieties that help in the growth and development of cancer. Therefore, combinatorial drug treatment using a co-crystal of multiple drugs gives researchers an idea of the development of a new type of drug for targeting multiple targets. In this study, a new co-crystal of chrysin and oroxylin A was isolated from the leaves of and its anticancer properties were studied in cervical cancer cells HeLa.

Aim

This study was conducted with the aim of identifying new anticancer compounds from the leaves of and studying the anticancer properties of the isolated compound.

Objective

In this study, we elucidated the structure of a new co-crystal compound, which was isolated from the leaf extract of The apoptosis induction mechanism of the newly discovered co-crystal in HeLa cells was also studied.

Methods

A crystal compound from the chloroform extract of leaves of was isolated by solvent fractionation and chromatographic methods involving HPLC. The molecular structure of the isolated crystal was elucidated by Single Crystal-XRD, FT-IR analysis, and further determined by LC-MS. The antiproliferative activity was carried out using an MTT assay and fluorescence microscopy, and the mechanism of apoptosis was determined using Western blotting techniques.

Results

The novel co-crystal consists of two active pharmaceutical ingredients (APIs) in a 1:1 ratio, ., oroxylin A and chrysin. The isolated new co-crystal induced death in HeLa cells with a very low IC value of 8.49µM. It induced caspase-dependent apoptosis in HeLa cells by activation of Caspase-3 through inhibition of ERKs and activation of p38 of MAPK cell signalling pathway.

Conclusion

This study presents the first report on the discovery of a naturally occurring co-crystal of chrysin and oroxylin A and the involvement of ERKs and p38 of MAPK pathways in the induction of apoptosis in HeLa cells by the co-crystal. Our study sheds light on the development of a co-crystal of chrysin and oroxylin A in a specific ratio of 1:1 for combination therapy of the two APIs. The purified co-crystal was found to be more efficient compared to the compounds present individually. Further analysis of the physiochemical properties and molecular mechanisms of the isolated co-crystal in different cancer cells is warranted for its application in therapeutics.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206364530241128044041
2024-12-13
2025-04-02

  • From This Site

    /content/journals/acamc/10.2174/0118715206364530241128044041
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ferlay J. Global Cancer Observatory: Cancer Today. Lyon, France International Agency for Research on Cancer 2020 10.1002/ijc.33588
    [Google Scholar]
  2. Guida F. Kidman R. Ferlay J. Schüz J. Soerjomataram I. Kithaka B. Ginsburg O. Mailhot Vega R.B. Galukande M. Parham G. Vaccarella S. Canfell K. Ilbawi A.M. Anderson B.O. Bray F. dos-Santos-Silva I. McCormack V. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat. Med. 2022 28 12 2563 2572 10.1038/s41591‑022‑02109‑2 36404355
    [Google Scholar]
  3. Ramírez M.H. López K.G. Carrancá A. Polyphenols as antitumor agents targeting key players in cancer-driving signaling pathways. Front. Pharmacol. 2021 12 710304 10.3389/fphar.2021.710304 34744708
    [Google Scholar]
  4. Golmohammadi M. Zamanian M.Y. Jalal S.M. Noraldeen S.A.M. Ramírez-Coronel A.A. Oudaha K.H. Obaid R.F. Almulla A.F. Bazmandegan G. Kamiab Z. A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action. Food Sci. Nutr. 2023 11 12 7458 7468 10.1002/fsn3.3699 38107139
    [Google Scholar]
  5. Guamán-Ortiz L. Orellana M. Ratovitski E. Natural compounds as modulators of non-apoptotic cell death in cancer cells. Curr. Genomics 2017 18 2 132 155 10.2174/1389202917666160803150639 28367073
    [Google Scholar]
  6. Zamanian M.Y. Golmohammadi M. Yumashev A. Hjazi A. Toama M.A. AbdRabou M.A. Gehlot A. Alwaily E.R. Shirsalimi N. Yadav P.K. Moriasi G. Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways. Cell Biochem. Funct. 2024 42 4 e4071 10.1002/cbf.4071 38863255
    [Google Scholar]
  7. Khan T. Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules. 2019 10 1 47 10.3390/biom10010047
    [Google Scholar]
  8. Van Hasselt J.C. Iyengar R.J.A. Systems pharmacology: Defining the interactions of drug combinations. Annu. Rev. Pharmacol. Toxicol. 2019 59 21 40 10.1146/annurev‑pharmtox‑010818‑021511
    [Google Scholar]
  9. Vakil V. Trappe W.J.P. Drug combinations: Mathematical modeling and networking methods. Pharmaceutics 2019 11 5 208 10.3390/pharmaceutics11050208
    [Google Scholar]
  10. Frantz S.J.N. The trouble with making combination drugs. Nat. Rev. Drug Discov. 2006 5 881 882 10.1038/nrd2188
    [Google Scholar]
  11. Wang X. Drug-drug cocrystals: Opportunities and challenges. Asian J. Pharm. Sci. 2021 16 3 307 317 10.1016/j.ajps.2020.06.004
    [Google Scholar]
  12. Kumar Bandaru R. Rout S.R. Kenguva G. Gorain B. Alhakamy N.A. Kesharwani P. Dandela R. Recent advances in pharmaceutical cocrystals: From bench to market. Front. Pharmacol. 2021 12 780582 10.3389/fphar.2021.780582 34858194
    [Google Scholar]
  13. Kara D.D. Rathnanand M. Cocrystals and drug–drug cocrystals of anticancer drugs: A perception towards screening techniques, preparation, and enhancement of drug properties. Crystals 2022 12 10 1337 10.3390/cryst12101337
    [Google Scholar]
  14. Singh V. Chaudhary A.J.I.J. A review on the taxonomy, ethnobotany, chemistry and pharmacology of Oroxylum indicum Vent. Indian J. Pharm. Sci. 2011 73 5 483 490 10.4103/0250‑474X.98981
    [Google Scholar]
  15. Wu B.L. Wu Z-W. Yang F. Shen X-F. Wang L. Chen B. Li F. Wang M-K. Flavonoids from the seeds of Oroxylum indicum and their anti-inflammatory and cytotoxic activities. Phytochem. Lett. 2019 32 66 69 10.1016/j.phytol.2019.05.003
    [Google Scholar]
  16. Yan R. Cao Y. Chen C. Dai H. Yu S. Wei J. Li H. Yang B. Antioxidant flavonoids from the seed of Oroxylum indicum. Fitoterapia 2011 82 6 841 848 10.1016/j.fitote.2011.04.006 21596112
    [Google Scholar]
  17. Chen J. Chen J. Lu J. Systematic elucidation of the mechanism of Oroxylum indicum via network pharmacology. Evid. Based Complement. Alternat. Med. 2020 2020 1 5354215 10.1155/2020/5354215 32733583
    [Google Scholar]
  18. Dinda B. SilSarma I. Dinda M. Rudrapaul P. Oroxylum indicum (L.) Kurz, an important Asian traditional medicine: From traditional uses to scientific data for its commercial exploitation. J. Ethnopharmacol. 2015 161 255 278 10.1016/j.jep.2014.12.027 25543018
    [Google Scholar]
  19. Singh A.R. Singh S.A. Singh T.D. Singh N.T. Machathoibi T.C. Singh O.M. Singh L.S. Bioassay-guided isolation of 2-[p-(2-Carboxyhydrazino)phenoxy]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol from Oroxylum indicum and the investigation of its molecular mechanism action of apoptosis induction. Pharmaceuticals 2022 15 5 559 10.3390/ph15050559 35631385
    [Google Scholar]
  20. Sheldrick G.M. A short history of SHELX. Acta Crystallogr. A 2008 64 1 112 122 10.1107/S0108767307043930 18156677
    [Google Scholar]
  21. Renkoğlu P. Çelebier M. Yegin A.B. HPLC determination of olanzapine and carbamazepine in their nicotinamide cocrystals and investigation of the dissolution profiles of cocrystal tablet formulations. Pharm. Dev. Technol. 2015 20 3 380 384 10.3109/10837450.2014.882937 24521464
    [Google Scholar]
  22. Raina R. Afroze N. Kedhari Sundaram M. Haque S. Bajbouj K. Hamad M. Hussain A. Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways. Eur. Rev. Med. Pharmacol. Sci. 2021 25 5 2206 2220 10.26355/eurrev_202103_25253 33755959
    [Google Scholar]
  23. Raina R. Hussain A. Almutary A.G. Haque S. Raza T. D’Souza A.C. Subramani S. Sajeevan A. Co-administration of chrysin and luteolin with cisplatin and topotecan exhibits a variable therapeutic value in human cancer cells, HeLa. ACS Omega 2023 8 44 41204 41213 10.1021/acsomega.3c04443 37970041
    [Google Scholar]
  24. Zhang T. Chen X. Qu L. Wu J. Cui R. Zhao Y. Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg. Med. Chem. 2004 12 23 6097 6105 10.1016/j.bmc.2004.09.013 15519155
    [Google Scholar]
  25. Khoo B.Y. Chua S.L. Balaram P. Apoptotic effects of chrysin in human cancer cell lines. Int. J. Mol. Sci. 2010 11 5 2188 2199 10.3390/ijms11052188 20559509
    [Google Scholar]
  26. Pawar J.S. Mustafa S. Ghosh I. Chrysin and Capsaicin induces premature senescence and apoptosis via mitochondrial dysfunction and p53 elevation in Cervical cancer cells. Saudi J. Biol. Sci. 2022 29 5 3838 3847 10.1016/j.sjbs.2022.03.011 35844432
    [Google Scholar]
  27. Li H.N. Nie F.F. Liu W. Dai Q.S. Lu N. Qi Q. Li Z.Y. You Q.D. Guo Q.L. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology 2009 257 1-2 80 85 10.1016/j.tox.2008.12.011 19135124
    [Google Scholar]
  28. Kiraly G. Simonyi A.S. Turani M. Micronucleus formation during chromatin condensation and under apoptotic conditions. Apoptosis 2017 22 2 207 219 10.1007/s10495‑016‑1316‑4
    [Google Scholar]
  29. Bossy-Wetzel E. Green D.R. Detection of apoptosis by annexin V labeling. Methods in enzymology. Elsevier 2000 15 18 10.1016/S0076‑6879(00)22004‑1
    [Google Scholar]
  30. Elmore S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007 35 4 495 516 10.1080/01926230701320337 17562483
    [Google Scholar]
  31. Guo Y.J. Pan W.W. Liu S.B. Shen Z.F. Xu Y. Hu L.L. ERK/MAPK signalling pathway and tumorigenesis (Review). Exp. Ther. Med. 2020 19 3 1997 2007 10.3892/etm.2020.8454 32104259
    [Google Scholar]
  32. Lavoie H. Gagnon J. Therrien M. ERK signalling: A master regulator of cell behaviour, life and fate. Nat. Rev. Mol. Cell Biol. 2020 21 10 607 632 10.1038/s41580‑020‑0255‑7 32576977
    [Google Scholar]
  33. Berra E. Diaz-Meco M.T. Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J. Biol. Chem. 1998 273 17 10792 10797 10.1074/jbc.273.17.10792 9553146
    [Google Scholar]
  34. Berra E. Municio M.M. Sanz L. Frutos S. Diaz-Meco M.T. Moscat J. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade. Mol. Cell. Biol. 1997 17 8 4346 4354 10.1128/MCB.17.8.4346 9234692
    [Google Scholar]
  35. Xia Z. Dickens M. Raingeaud J. Davis R.J. Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995 270 5240 1326 1331 10.1126/science.270.5240.1326 7481820
    [Google Scholar]
  36. Yang C. Luo J. Luo X. Jia W. Fang Z. Yi S. Li L. Morusin exerts anti-cancer activity in renal cell carcinoma by disturbing MAPK signaling pathways. Ann. Transl. Med. 2020 8 6 327 10.21037/atm.2020.02.107 32355771
    [Google Scholar]
  37. Eid W. Abdel-Rehim W. Neferine enhances the antitumor effect of mitomycin‐C in hela cells through the activation of p38‐MAPK pathway. J. Cell. Biochem. 2017 118 10 3472 3479 10.1002/jcb.26006 28328092
    [Google Scholar]
  38. Yao W. Lin Z. Wang G. Li S. Chen B. Sui Y. Huang J. Liu Q. Shi P. Lin X. Liu Q. Yao H. Delicaflavone induces apoptosis via mitochondrial pathway accompanying G2/M cycle arrest and inhibition of MAPK signaling cascades in cervical cancer HeLa cells. Phytomedicine 2019 62 152973 10.1016/j.phymed.2019.152973 31177019
    [Google Scholar]
  39. Thakuria R. Sarma B.J.C. Drug-drug and drug-nutraceutical cocrystal/salt as alternative medicine for combination therapy: A crystal engineering approach. Crystals 2018 2 101 10.3390/cryst8020101
    [Google Scholar]
  40. Kumbhar P. Kolekar K. Co-crystal nanoarchitectonics as an emerging strategy in attenuating cancer: Fundamentals and applications. J. Control Release. 2023 353 1150 1170 10.1016/j.jconrel.2022.12.042
    [Google Scholar]
  41. Nascimento A.L. Fernandes R.P. Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): Insight toward formation, methods, and drug enhancement. Particuology 2021 58 227 241 10.1016/j.partic.2021.03.015
    [Google Scholar]
/content/journals/acamc/10.2174/0118715206364530241128044041
Loading
Discovery of a Novel Co-crystal of Chrysin and Oroxylin a with Anticancer Properties from Leaves of Oroxylum indicum
Bentham Science Publishers ; https://doi.org/10.2174/0118715206364530241128044041
/content/journals/acamc/10.2174/0118715206364530241128044041
/content/journals/acamc/10.2174/0118715206364530241128044041
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: caspase 3 ; Oroxylum indicum ; apoptosis ; MAPK ; HeLa ; chrysin ; co-crystal ; oroxylin A

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test